| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.56▲ | 6.51▲ | 6.50▲ | 6.34▲ | 6.19▲ |
| MA10 | 6.52▲ | 6.47▲ | 6.38▲ | 6.46▲ | 5.76▲ |
| MA20 | 6.49▲ | 6.38▲ | 6.39▲ | 6.29▲ | 5.20▲ |
| MA50 | 6.47▲ | 6.42▲ | 6.42▲ | 5.72▲ | 5.42▲ |
| MA100 | 6.39▲ | 6.43▲ | 6.45▲ | 5.16▲ | 3.89▲ |
| MA200 | 6.39▲ | 6.43▲ | 6.11▲ | 5.77▲ | 2.98▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.025▲ | 0.032▲ | -0.043▼ | 0.186▲ |
| RSI | 72.242▲ | 63.039▲ | 60.609▲ | 58.461▲ | 64.740▲ |
| STOCH | 83.962▲ | 78.178 | 72.783 | 39.618 | 77.396 |
| WILL %R | -3.125▲ | -5.505▲ | -5.505▲ | -24.720▲ | -6.985▲ |
| CCI | 134.979▲ | 158.159▲ | 139.880▲ | 14.460 | 106.318▲ |
|
Thursday, August 06, 2026 01:30 AM
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the second quarter ended June 30 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 6.30 | 6.6212 | 6.2063 | 6.60 | 5,077,643 |
| 06/08/26 | 6.06 | 6.63 | 6.0214 | 6.11 | 8,389,019 |
| 05/08/26 | 6.49 | 6.57 | 6.34 | 6.37 | 4,894,778 |
| 04/08/26 | 6.26 | 6.535 | 6.21 | 6.44 | 4,046,035 |
| 03/08/26 | 6.36 | 6.42 | 6.075 | 6.16 | 4,714,385 |
| 31/07/26 | 6.68 | 6.69 | 6.295 | 6.33 | 3,931,615 |
| 30/07/26 | 6.49 | 6.75 | 6.415 | 6.70 | 4,806,871 |
| 29/07/26 | 6.64 | 6.77 | 6.39 | 6.59 | 6,477,810 |
| 28/07/26 | 6.66 | 6.7272 | 6.41 | 6.69 | 4,986,714 |
| 27/07/26 | 6.605 | 6.79 | 6.53 | 6.66 | 6,026,684 |
|
|
||||
|
|
||||
|
|